← Leaderboards
Paul Thornton
Xeris Pharmaceuticals, Inc.
$1,036,601
Attributed
$2,073,201
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $833.1K · FY2015–17$1M$750K$500K$250K$0
'15
'16
'17
Funding mix
By agency
NIH$2,073,201 · 1
By mechanism
R44$2,073,201 · 1
Top collaborators
- Steven Prestrelski3 shared
Most similar at Xeris Pharmaceuticals, Inc.
Same institution · by research overlap
- Steven Prestrelski$2,954,783
- John Kinzell$1,476,967
Others in their field
Top investigators on “Drug Clearance”
- Sharon A Nachman · Johns Hopkins University$212,600,639
- Nevan J Krogan · University Of California, San Francisco$67,452,049
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$60,104,394
- Xinhua Li · Nano Terra, Inc.$36,275,012
- Robert A Rissman · University Of California Irvine$24,784,138
- Kristine Yaffe · American Federation For Aging Research$21,969,486
Research focus
Drug ClearanceEventAdverse EffectsAdolescenceAdolescentDrug InteractionsBrain InjuriesCarbohydratesAnimalsCaringChildChronicBlood Glucose5 Year OldClinical TrialsComplexConduct Clinical TrialsContinuous InfusionCaregiversCyclic GmpDesignDietDiffuseExposed Human Population